SEC Clinical Research

Clinical research site in Dothan, Alabama

Part of SEC Clinical Research

As of July 2026, 5 paid clinical trials are recruiting at SEC Clinical Research in Dothan, Alabama. Active studies at this site cover conditions such as Atrial Fibrillation (AF), Healthy and Heart Failure With Mildly Reduced Ejection Fraction. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at SEC Clinical Research (5)

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

for Moderate to Severe Chronic Obstructive Pulmonary Disease

50 locations incl. Birmingham

Sponsor: Pfizer

Sex: All·Age: 35 - 80

Code: NCT07363694·Phase 2, Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

for Healthy

122 locations incl. Birmingham

Sponsor: Pfizer

Sex: All·Age: 1 Day - 49·Accepts healthy volunteers

Code: NCT07160244·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

for Atrial Fibrillation (AF)

39 locations incl. Dothan

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07175428·Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

for Heart Failure With Preserved Ejection Fraction

110 locations incl. Birmingham

Sponsor: Amgen

Sex: All·Age: 18 - 99

Code: NCT07037459·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

for Atrial Fibrillation (AF)

18 locations incl. Dothan

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07430956·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

More research sites in Dothan

Trinity Research Group (4 trials)
Glaukos Investigative Site (3 trials)
Harmonex Neuroscience Research (3 trials)
Digestive Health Specialists (3 trials)
Akero Clinical Study Site (2 trials)
Digestive Health Specialists of the Southeast (Gastroenterology Associates of Dothan) - Dothan (2 trials)
Digestive Health Specialsits (2 trials)
Alkermes Investigational Site (1 trial)
Alkermes Investigator Site (1 trial)
Clinical Study Center (1 trial)

Explore more

Paid clinical trials in Dothan, AL · Alabama clinical trials